Axsome Therapeutics, Inc. (AXSM) vs Kymera Therapeutics, Inc. (KYMR)
- Axsome Therapeutics, Inc. AXSM 157.14 −2.87%
- Kymera Therapeutics, Inc. KYMR 104.78 −3.11%
Axsome Therapeutics, Inc. and Kymera Therapeutics, Inc. are both Biotechnology companies. Axsome Therapeutics, Inc. and Kymera Therapeutics, Inc. are of similar size ($9.0B and $8.5B). Kymera Therapeutics, Inc. grew revenue faster over the last twelve months: 134.8% against 56.9%. Axsome Therapeutics, Inc. has the higher net margin (−24.7% vs −285.3%) and the higher return on invested capital (0.00% vs −26.7%). Across the 17 metrics below, Axsome Therapeutics, Inc. leads on 10 and Kymera Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | AXSM | KYMR | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.24% | 100.00% | 65.16% |
| Operating margin | (23.96%) | (333.50%) | 0.00% |
| Net margin | (24.68%) | (285.33%) | 0.00% |
| Free cash flow margin | (9.27%) | (226.62%) | 0.00% |
| Return on equity | (245.10%) | (24.15%) | (56.36%) |
| Return on assets | (27.35%) | (21.58%) | (48.04%) |
| Return on invested capital | 0.00% | (26.72%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack